4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000124
Options or other derivatives
- Chief Executive Officer acquired 2,964,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Venker Eric Chief Executive Officer | 2025-07-28 | Grant or award · Stock Option (right to buy) | +1,300,000 | 1,300,000 | D | ||
| Venker Eric Chief Executive Officer | 2025-07-28 | Grant or award · Stock Option (right to buy) | +189,900 | 189,900 | D | ||
| Venker Eric Chief Executive Officer | 2025-07-28 | Grant or award · Capped Value Appreciation Rights | +1,475,000 | 1,475,000 | D | ||
Loading xslF345X05/wk-form4_1753912582.xml…